According to a study, a significantly reduced mortality risk may be seen in patients with chronic obstructive pulmonary disease (COPD) and using inhaled corticosteroids.

It was shown by the research that patients receiving inhaled corticosteroids within 30 days of hospital discharge had a twenty-five percent minimized all-cause mortality rate while numbers of cardiovascular-pertaining death alone in patients using steroids paired with beta-agonist were reduced by thirty-eight percent.

From News-Medical.Net:

Dr. Macie and colleagues found that the mortality rates in patients 65+ who received inhaled corticosteroids were 11.7 percent, compared with 13.1 percent for those who did not. Patients in the younger group showed even greater results, with a mortality rate of 3.0 percent for patients receiving inhaled corticosteroids within 90 days, compared with 6.0 percent for those who did not, providing a mortality reduction rate of 53 percent. When patients who received steroids in the year prior were removed from the analysis, mortality was reduced by 34 percent. Researchers attribute this finding to multifactorial reasons, including reductions in exacerbations of the disease and suppression of inflammation.

Researchers also found a 23 percent reduced risk of death when comparing the effects of inhaled steroids with bronchodilators in patients in the 65+ group. In all cases, the most significant results were found when inhaled corticosteroids were administered within the first 30 days following hospital discharge.

Author Christine Macie, MD, FCCP, Cambridge Hospital, Ontario, Canada, remarked that this study analyzed the effect of inhaled corticosteroids on survival and the study results suggest that survival is longer in patients using inhaled corticosteroids.

Bookmark It

Hide Sites

Tags: chronic obstructive pulmonary disease, COPD, inhaled corticosteroids, steroids

Posted in Steroid Cycles, Steroids and Anabolic Steroids, buy steroids, steroid nation